GRACEcast-144_Lung-Cancer_Dr. Leighl on Highlights of MEK Inhibitors for KRAS Mutation

cancergrace has 1135 videos Subscribe Here

Description: Dr. Natasha Leighl, Princess Margaret Hospital in Toronto, Canada, reviews exciting new data illustrating the potential benefits of the MEK inhibitor selumetinib in treating KRAS mutation-positive advanced non-small cell lung cancer.
Shared By : cancergrace
Posted on : 04/30/13
Added : 6 years ago